Nipun Davar's appointment, with his vast experience in small...

Nipun Davar's appointment, with his vast experience in small molecule product development and commercial manufacturing, is a major boost for RAPT's leadership team as they progress their drug candidates zelnecirnon and tivumecirnon in late-stage clinical trials for inflammatory diseases and oncology indications.